SCNI

#5247
Scinai Immunotherapeutics Ltd - American Depositary Shares
0.0 0 USD
+2.27%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.00
0.00
Year Range
0.00
1.05
Daily Change
+2.27%
Monthly Change
-99.36%
6 month change
-99.40%
Year Change
-99.40%
Previous Close
0.0 0
Open
0.0 0
Low
0.0 0
High
0.0 0
Volume
3
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 15.61 K
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
791.22
Price to sales ratio
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

News